Schouw, H. M. http://orcid.org/0000-0002-8996-4353
Huisman, L. A.
Janssen, Y. F. http://orcid.org/0000-0003-1271-3780
Slart, R. H. J. A.
Borra, R. J. H. http://orcid.org/0000-0001-8072-1243
Willemsen, A. T. M.
Brouwers, A. H. http://orcid.org/0000-0003-2698-1516
van Dijl, J. M. http://orcid.org/0000-0002-5688-8438
Dierckx, R. A.
van Dam, G. M. http://orcid.org/0000-0002-7248-8696
Szymanski, W. http://orcid.org/0000-0002-9754-9248
Boersma, H. H. http://orcid.org/0000-0003-1892-9830
Kruijff, S. http://orcid.org/0000-0002-5151-7320
Article History
Received: 31 May 2021
Accepted: 23 July 2021
First Online: 11 October 2021
Declarations
:
: GMvD is founder, owner and CEO of AxelaRx/TRACER Europe BV, a contract research organisation.
: Not applicable.
: Not applicable.
: Not applicable.